BSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 08/18/2026 15:50
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization169,953 mln
Float30.85 mln
EPS
49.04
Exceptional
P / E
28.53
Elevated
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.18
Caution advised
1-Year Forecast
1,359
Fairly priced
Relative Strength
77
/ 100
Strongly outperforming
Business Description
Alivus Life Sciences Limited, formerly Glenmark Life Sciences and now a subsidiary of Nirma Limited, is a Mumbai-based company founded in 2001 that produces and sells active pharmaceutical ingredients across markets in India, Japan, Europe, and the Americas. The company supplies ingredients used in treatments for a wide range of health conditions, including heart disease, diabetes, cancer, and neurological disorders. It also manufactures pharmaceutical products on behalf of large multinational companies and specialty firms under contract arrangements.
